Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

Diphtheria Clinical Manifestations and Complications

Primary Clinical Manifestations

  • The Centers for Disease Control and Prevention recommends that diphtheria be characterized by sore throat, low-grade fever, and an adherent gray-colored pseudomembrane of the tonsil(s), pharynx, and/or nose 1, 2
  • Sore throat is a hallmark symptom, often the first indication of infection, according to the Centers for Disease Control and Prevention 1, 3
  • Low-grade fever commonly accompanies the infection, as reported by the Centers for Disease Control and Prevention 1, 3
  • The most distinctive feature is the development of a gray-colored pseudomembrane that is firmly adherent to the mucosa lining the nasopharynx, tonsils, pharynx, larynx, and nose, as described by the Centers for Disease Control and Prevention 1, 2, 3, 4

Progression and Complications

  • Extension of the pseudomembrane into the trachea-bronchial tree can cause life-threatening airway obstruction, according to the Centers for Disease Control and Prevention 2, 4
  • Systemic absorption and dissemination of diphtheria toxin can lead to serious complications, including cardiac complications (toxin-mediated myocarditis) and neurologic complications (toxin-mediated neuropathy), as reported by the Centers for Disease Control and Prevention 2, 4, 5

Risk Factors for Severe Disease

  • Vaccination status is a significant risk factor, with unvaccinated or inadequately vaccinated individuals being at highest risk, according to the Centers for Disease Control and Prevention 6, 7

Clinical Variants

  • Cutaneous diphtheria can also occur but is not reportable in the United States, as stated by the Centers for Disease Control and Prevention 1, 3